Aspartic Acid - Lenvima (Lenvatinib) Interaction
Herbal: Aspartic Acid
Also Known As: 2-Aminobutanedioic acid
Drug: Lenvatinib
Brand names:
Lenvima
Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
Jun 22, 2025
Interaction Details
There were no interactions found between Lenvatinib and Aspartic Acid. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Aspartic Acid Overview
Aspartic acid, also known as aspartate, is a non-essential amino acid that plays a crucial role in various physiological processes within the body. It functions as a building block in protein synthesis and is a central component of various enzymes. Additionally, aspartic acid plays a key role in the metabolism of nitrogen.
Aspartic acid has been studied for its potential benefits as a dietary supplement. Research indicates that it may aid in cognitive function and memory by increasing the levels of the neurotransmitter acetylcholine, which is critical for memory and learning. Furthermore, aspartic acid has been suggested to enhance athletic performance by increasing energy and endurance through the elevation of creatine levels. It is worth mentioning that aspartame, an artificial sweetener, contains around 40% aspartic acid.
Aspartic acid exists in two forms, D-aspartic acid (D-AA) and L-aspartic acid (L-AA). The structural difference between the two forms is the arrangement of atoms in their molecular structure. D-aspartic acid is more commonly found in dietary supplements for athletics, as it has been studied for its effects on testosterone levels and muscle growth.
Lenvatinib Overview
-
Lenvatinib is used to treat a certain type of thyroid cancer that has returned or that has spread to other parts of the body and cannot be treated with radioactive iodine. Lenvatinib is also used along with everolimus (Afinitor, Zortress) to treat renal cell carcinoma (RCC, a type of cancer that begins in the kidney) in people who have previously received treatment with another chemotherapy medication. Lenvatinib is also used along with pembrolizumab (Keytruda) as an initial treatment for advanced renal cell carcinoma. Lenvatinib is also used to treat hepatocellular carcinoma (HCC; a type of liver cancer) that cannot be treated with surgery. Lenvatinib is also used along with pembrolizumab (Keytruda) to treat a certain type of cancer of the endometrium (lining of the uterus) that has spread to other parts of the body or worsened during or after treatment with chemotherapy medications or that cannot be treated with surgery or radiation therapy. Lenvatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
Aspartic Acid - More Interactions
Aspartic Acid interacts with 0 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
| Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
| Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
| Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
| Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.
Ask A Pharmacist About Your Herbal Questions!
Dr. Brian Staiger, PharmD
In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!
Ask A Pharmacist